CAS RN: 88056-92-2
(-)-2-Cyano-6-phenyloxazolopiperidine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250312
200mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 88056-92-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
88056-92-2 / 3-phenyl-3,5,6,7,8,8a-hexahydro-2H-[1,3]oxazolo[3,2-a]pyridine-5-carbonitrile
Standard CAS: 88056-92-2
Multi CAS: Yes
Basic Information
copy
CAS
88056-92-2 copy
Multi CAS
Yes copy
Molecular Formula
C14H16N2O copy
Molecular Weight
228.290000 copy
Exact Mass
228.126263 copy
InChI
InChI=1S/C14H16N2O/c15-9-12-7-4-8-14-16(12)13(10-17-14)11-5-2-1-3-6-11/h1-3,5-6,12-14H,4,7-8,10H2 copy
InChIKey
GQHMNZGZXHZLEN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
Molar refractivity
64.01 copy
TPSA
36.26 copy
LogP / Solubility
WLOGP
2.46 copy
MLOGP
2.17 copy
XLogP3
2.2 copy
Consensus LogP
2.28 copy
Log S (ESOL)
-3 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.21 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.31 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.36 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy